Surge Laboratories since its inception has been focused on developing new & innovative branded generic products in the region and has invested significantly in Research and Development. The company over the years has invested not only in the latest cutting–edge technology for Research and Development but also has a team of highly qualified, experienced, trained, and highly skilled research scientists to meet international standards.
Parenteral Product Development
Surge has successfully developed one of the most compelling, enlightening, and modern Research and Development facilities in the country which can develop products at the lab scale for the following dosage forms:
Small Volume Parenteral (from 0.5ml -20ml) in ampoules
Large Volume Parenteral (from 50ml -250ml) in Vials
Blow-Fill-Seal (BFS) for Infusions and Inhalation Products.
Sterile Dry Powder Injectables in Vials (General)
Surge Laboratories, we strategically collaborated with technology providers from Western Europe and introduced the first-ever microencapsulation technology in the country through which we started developing various specialized/value-added microencapsulated APIs and Excipients. The most advanced and latest technology installed at Surge includes lab, pilot, commercial, and bulk scale cGMP compliant microencapsulation equipment from Germany through which a series of following coating operations can be performed with high precision and quality:Highly Effective and stable Taste Masking of Bitter Molecules,
Formulation of APIs into High-Quality Enteric Coated Pellets
Coating of APIs for Controlled & Targeted Drug Release/ Delivery
Moisture Protective Coating for Moisture Sensitive Materials for Effervescent Sachet
Coating of Granules which can be used for the Orally Dispersible Tablets and Combination Tablets